These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
152 related articles for article (PubMed ID: 19419702)
1. Cellular immortality in brain tumours: an integration of the cancer stem cell paradigm. Rahman R; Heath R; Grundy R Biochim Biophys Acta; 2009 Apr; 1792(4):280-8. PubMed ID: 19419702 [TBL] [Abstract][Full Text] [Related]
2. Brain tumour stem cells: the undercurrents of human brain cancer and their relationship to neural stem cells. Dirks PB Philos Trans R Soc Lond B Biol Sci; 2008 Jan; 363(1489):139-52. PubMed ID: 17309866 [TBL] [Abstract][Full Text] [Related]
5. Tissue formation and tissue engineering through host cell recruitment or a potential injectable cell-based biocomposite with replicative potential: Molecular mechanisms controlling cellular senescence and the involvement of controlled transient telomerase activation therapies. Babizhayev MA; Yegorov YE J Biomed Mater Res A; 2015 Dec; 103(12):3993-4023. PubMed ID: 26034007 [TBL] [Abstract][Full Text] [Related]
7. Identification of brain tumour initiating cells using the stem cell marker aldehyde dehydrogenase. Choi SA; Lee JY; Phi JH; Wang KC; Park CK; Park SH; Kim SK Eur J Cancer; 2014 Jan; 50(1):137-49. PubMed ID: 24103144 [TBL] [Abstract][Full Text] [Related]
8. Role of telomerase in the tumour microenvironment. Liu N; Guo XH; Liu JP; Cong YS Clin Exp Pharmacol Physiol; 2020 Mar; 47(3):357-364. PubMed ID: 31799699 [TBL] [Abstract][Full Text] [Related]
9. Multiple pathways for the regulation of telomerase activity. Holt SE; Wright WE; Shay JW Eur J Cancer; 1997 Apr; 33(5):761-6. PubMed ID: 9282114 [TBL] [Abstract][Full Text] [Related]
10. Telomere dynamics and telomerase activity in in vitro immortalised human cells. Bryan TM; Reddel RR Eur J Cancer; 1997 Apr; 33(5):767-73. PubMed ID: 9282115 [TBL] [Abstract][Full Text] [Related]
11. Neural tumor-initiating cells have distinct telomere maintenance and can be safely targeted for telomerase inhibition. Castelo-Branco P; Zhang C; Lipman T; Fujitani M; Hansford L; Clarke I; Harley CB; Tressler R; Malkin D; Walker E; Kaplan DR; Dirks P; Tabori U Clin Cancer Res; 2011 Jan; 17(1):111-21. PubMed ID: 21208905 [TBL] [Abstract][Full Text] [Related]
13. Analysis of telomerase activity and telomere function in cancer. Gordon KE; Parkinson EK Methods Mol Biol; 2004; 281():333-48. PubMed ID: 15220541 [TBL] [Abstract][Full Text] [Related]
14. Targeting the telosome: therapeutic implications. Folini M; Gandellini P; Zaffaroni N Biochim Biophys Acta; 2009 Apr; 1792(4):309-16. PubMed ID: 19419699 [TBL] [Abstract][Full Text] [Related]
15. Clinical implications of telomerase in cancer. Kim NW Eur J Cancer; 1997 Apr; 33(5):781-6. PubMed ID: 9282117 [TBL] [Abstract][Full Text] [Related]
16. Overcoming the immortality of tumour cells by telomere and telomerase based cancer therapeutics--current status and future prospects. Kelland LR Eur J Cancer; 2005 May; 41(7):971-9. PubMed ID: 15862745 [TBL] [Abstract][Full Text] [Related]
17. Use of telomerase to create bioengineered tissues. Shay JW; Wright WE Ann N Y Acad Sci; 2005 Dec; 1057():479-91. PubMed ID: 16399914 [TBL] [Abstract][Full Text] [Related]
18. Telomeres and telomerase in cancer stem cells. Ju Z; Rudolph KL Eur J Cancer; 2006 Jun; 42(9):1197-203. PubMed ID: 16644207 [TBL] [Abstract][Full Text] [Related]
19. Spontaneous transformation of human adult nontumorigenic stem cells to cancer stem cells is driven by genomic instability in a human model of glioblastoma. Shiras A; Chettiar ST; Shepal V; Rajendran G; Prasad GR; Shastry P Stem Cells; 2007 Jun; 25(6):1478-89. PubMed ID: 17332509 [TBL] [Abstract][Full Text] [Related]
20. Telomere biology of pediatric cancer. Tabori U; Dome JS Cancer Invest; 2007; 25(3):197-208. PubMed ID: 17530490 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]